Detail publikačního výsledku

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

CHYRÁ, Z.; ŠEVČÍKOVÁ, T.; VOJTA, P.; PUTEROVÁ, J.; BROŽOVÁ, L.; GROWKOVÁ, K.; FILIPOVÁ, J.; ZÁTOPKOVÁ, M.; GROSICKI, S.; BARCHANICKA, A.; JĘDRZEJCZAK, W.; WASZCZUK-GAJDA, A.; JUNGOVÁ, A.; MIKULÁŠOVÁ, A.; HAJDÚCH, M.; MOKREJŠ, M.; POUR, L.; ŠTORK, M.; HARVANOVÁ, Ľ.; MISTRÍK, M.; MIKALA, G.; ROBAK, P.; CZYŻ, A.; DĘBSKI, J.; USNARSKA-ZUBKIEWICZ, L.; JURCZYSZYN, A.; STEJSKAL, L.; MORGAN, G.; KRYUKOV, F.; BUDINSKÁ, E.; ŠIMÍČEK, M.; JELÍNEK, T.; HRDINKA, M.; HÁJEK, R.

Originální název

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Anglický název

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis

Druh

Článek WoS

Originální abstrakt

We aim to provide the very first insight into ALA (amyloidosis) +MM (multiple myeloma) molecular profiles and compare the results with ALA and with MM. Our detailed study of ALA and ALA+MM represents an important step towards the improved understanding of their genetic and transcriptomic background, which is a
prerequisite for the development of optimal treatment strategies in the future.

Anglický abstrakt

We aim to provide the very first insight into ALA (amyloidosis) +MM (multiple myeloma) molecular profiles and compare the results with ALA and with MM. Our detailed study of ALA and ALA+MM represents an important step towards the improved understanding of their genetic and transcriptomic background, which is a
prerequisite for the development of optimal treatment strategies in the future.

Klíčová slova

amyloidosis, multiple myeloma, clonality, cancer

Klíčová slova v angličtině

amyloidosis, multiple myeloma, clonality, cancer

Autoři

CHYRÁ, Z.; ŠEVČÍKOVÁ, T.; VOJTA, P.; PUTEROVÁ, J.; BROŽOVÁ, L.; GROWKOVÁ, K.; FILIPOVÁ, J.; ZÁTOPKOVÁ, M.; GROSICKI, S.; BARCHANICKA, A.; JĘDRZEJCZAK, W.; WASZCZUK-GAJDA, A.; JUNGOVÁ, A.; MIKULÁŠOVÁ, A.; HAJDÚCH, M.; MOKREJŠ, M.; POUR, L.; ŠTORK, M.; HARVANOVÁ, Ľ.; MISTRÍK, M.; MIKALA, G.; ROBAK, P.; CZYŻ, A.; DĘBSKI, J.; USNARSKA-ZUBKIEWICZ, L.; JURCZYSZYN, A.; STEJSKAL, L.; MORGAN, G.; KRYUKOV, F.; BUDINSKÁ, E.; ŠIMÍČEK, M.; JELÍNEK, T.; HRDINKA, M.; HÁJEK, R.

Rok RIV

2022

Vydáno

06.02.2021

ISSN

1592-8721

Periodikum

HAEMATOLOGICA

Svazek

106

Číslo

2

Stát

Italská republika

Strany od

601

Strany do

604

Strany počet

4

URL

https://haematologica.org/article/view/9744

BibTex

@article{BUT168529,
  author="CHYRÁ, Z. and ŠEVČÍKOVÁ, T. and VOJTA, P. and PUTEROVÁ, J. and BROŽOVÁ, L. and GROWKOVÁ, K. and FILIPOVÁ, J. and ZÁTOPKOVÁ, M. and GROSICKI, S. and BARCHANICKA, A. and JĘDRZEJCZAK, W. and WASZCZUK-GAJDA, A. and JUNGOVÁ, A. and MIKULÁŠOVÁ, A. and HAJDÚCH, M. and MOKREJŠ, M. and POUR, L. and ŠTORK, M. and HARVANOVÁ, Ľ. and MISTRÍK, M. and MIKALA, G. and ROBAK, P. and CZYŻ, A. and DĘBSKI, J. and USNARSKA-ZUBKIEWICZ, L. and JURCZYSZYN, A. and STEJSKAL, L. and MORGAN, G. and KRYUKOV, F. and BUDINSKÁ, E. and ŠIMÍČEK, M. and JELÍNEK, T. and HRDINKA, M. and HÁJEK, R.",
  title="Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis",
  journal="HAEMATOLOGICA",
  year="2021",
  volume="106",
  number="2",
  pages="601--604",
  doi="10.3324/haematol.2019.239756",
  issn="0390-6078",
  url="https://haematologica.org/article/view/9744"
}

Dokumenty

9744-Article Text-71470-2-10-20210126